vs
Side-by-side financial comparison of ACNB CORP (ACNB) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
ACNB CORP is the larger business by last-quarter revenue ($47.2M vs $39.6M, roughly 1.2× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs 22.9%, a 13.0% gap on every dollar of revenue. On growth, ACNB CORP posted the faster year-over-year revenue change (42.2% vs -10.9%). ACNB CORP produced more free cash flow last quarter ($52.6M vs $51.2M). Over the past eight quarters, ACNB CORP's revenue compounded faster (22.1% CAGR vs -15.0%).
ACNB Corp is a US-based financial holding company headquartered in Pennsylvania. It provides a full suite of financial solutions including retail and commercial banking, wealth management, trust services, and property & casualty insurance products. Its core market covers local communities, individual consumers, and small-to-medium enterprises across south-central Pennsylvania and northern Maryland.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
ACNB vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.2M | $39.6M |
| Net Profit | $10.8M | $14.2M |
| Gross Margin | — | 73.1% |
| Operating Margin | 27.9% | 32.5% |
| Net Margin | 22.9% | 35.9% |
| Revenue YoY | 42.2% | -10.9% |
| Net Profit YoY | 63.8% | 117.2% |
| EPS (diluted) | $1.10 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.2M | $39.6M | ||
| Q3 25 | $50.9M | $43.4M | ||
| Q2 25 | $50.3M | $43.4M | ||
| Q1 25 | $43.5M | $47.3M | ||
| Q4 24 | $33.2M | $44.4M | ||
| Q3 24 | $34.1M | $53.1M | ||
| Q2 24 | $33.3M | $53.1M | ||
| Q1 24 | $31.6M | $54.8M |
| Q4 25 | $10.8M | $14.2M | ||
| Q3 25 | $14.9M | $12.8M | ||
| Q2 25 | $11.6M | $2.5M | ||
| Q1 25 | $-272.0K | $21.5M | ||
| Q4 24 | $6.6M | $6.5M | ||
| Q3 24 | $7.2M | $2.8M | ||
| Q2 24 | $11.3M | $18.5M | ||
| Q1 24 | $6.8M | $18.8M |
| Q4 25 | — | 73.1% | ||
| Q3 25 | — | 70.6% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 79.7% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 81.5% | ||
| Q2 24 | — | 74.2% | ||
| Q1 24 | — | 72.1% |
| Q4 25 | 27.9% | 32.5% | ||
| Q3 25 | 37.2% | 36.6% | ||
| Q2 25 | 29.7% | 33.6% | ||
| Q1 25 | -1.3% | 51.1% | ||
| Q4 24 | 24.8% | 10.6% | ||
| Q3 24 | 27.6% | 26.1% | ||
| Q2 24 | 42.8% | 51.4% | ||
| Q1 24 | 26.9% | 44.6% |
| Q4 25 | 22.9% | 35.9% | ||
| Q3 25 | 29.2% | 29.6% | ||
| Q2 25 | 23.2% | 5.7% | ||
| Q1 25 | -0.6% | 45.4% | ||
| Q4 24 | 19.9% | 14.7% | ||
| Q3 24 | 21.1% | 5.3% | ||
| Q2 24 | 33.9% | 34.8% | ||
| Q1 24 | 21.4% | 34.2% |
| Q4 25 | $1.10 | $0.15 | ||
| Q3 25 | $1.42 | $0.12 | ||
| Q2 25 | $1.11 | $0.02 | ||
| Q1 25 | $-0.03 | $0.21 | ||
| Q4 24 | $0.77 | $0.05 | ||
| Q3 24 | $0.84 | $0.03 | ||
| Q2 24 | $1.32 | $0.20 | ||
| Q1 24 | $0.80 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $65.6M | $164.1M |
| Total DebtLower is stronger | $255.4M | $42.8M |
| Stockholders' EquityBook value | $420.0M | $248.3M |
| Total Assets | $3.2B | $380.4M |
| Debt / EquityLower = less leverage | 0.61× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $65.6M | $164.1M | ||
| Q3 25 | $102.1M | $127.4M | ||
| Q2 25 | $103.1M | $152.7M | ||
| Q1 25 | $123.6M | $132.1M | ||
| Q4 24 | $47.3M | $125.0M | ||
| Q3 24 | $58.1M | $137.4M | ||
| Q2 24 | $86.3M | — | ||
| Q1 24 | $53.1M | — |
| Q4 25 | $255.4M | $42.8M | ||
| Q3 25 | $255.4M | $21.1M | ||
| Q2 25 | $255.4M | $7.1M | ||
| Q1 25 | $255.3M | $6.9M | ||
| Q4 24 | $255.3M | $6.6M | ||
| Q3 24 | $255.3M | $823.2K | ||
| Q2 24 | $255.3M | — | ||
| Q1 24 | $255.3M | — |
| Q4 25 | $420.0M | $248.3M | ||
| Q3 25 | $408.6M | $248.0M | ||
| Q2 25 | $395.2M | $244.6M | ||
| Q1 25 | $386.9M | $226.4M | ||
| Q4 24 | $303.3M | $195.1M | ||
| Q3 24 | $306.8M | $205.0M | ||
| Q2 24 | $289.3M | $8.8M | ||
| Q1 24 | $279.9M | $9.0M |
| Q4 25 | $3.2B | $380.4M | ||
| Q3 25 | $3.3B | $321.4M | ||
| Q2 25 | $3.3B | $315.3M | ||
| Q1 25 | $3.3B | $284.6M | ||
| Q4 24 | $2.4B | $266.1M | ||
| Q3 24 | $2.4B | $296.5M | ||
| Q2 24 | $2.5B | $19.5M | ||
| Q1 24 | $2.4B | $19.8M |
| Q4 25 | 0.61× | 0.17× | ||
| Q3 25 | 0.62× | 0.09× | ||
| Q2 25 | 0.65× | 0.03× | ||
| Q1 25 | 0.66× | 0.03× | ||
| Q4 24 | 0.84× | 0.03× | ||
| Q3 24 | 0.83× | 0.00× | ||
| Q2 24 | 0.88× | — | ||
| Q1 24 | 0.91× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $53.6M | $52.0M |
| Free Cash FlowOCF − Capex | $52.6M | $51.2M |
| FCF MarginFCF / Revenue | 111.4% | 129.3% |
| Capex IntensityCapex / Revenue | 2.3% | 2.0% |
| Cash ConversionOCF / Net Profit | 4.96× | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $92.2M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $53.6M | $52.0M | ||
| Q3 25 | $23.2M | $-20.9M | ||
| Q2 25 | $17.8M | $-8.3M | ||
| Q1 25 | $-71.0K | $1.9M | ||
| Q4 24 | $39.8M | $-7.3M | ||
| Q3 24 | $13.6M | $5.0M | ||
| Q2 24 | $9.7M | $19.2M | ||
| Q1 24 | $10.8M | $3.7M |
| Q4 25 | $52.6M | $51.2M | ||
| Q3 25 | $22.8M | $-20.9M | ||
| Q2 25 | $17.6M | $-8.6M | ||
| Q1 25 | $-730.0K | $1.7M | ||
| Q4 24 | $38.8M | $-7.9M | ||
| Q3 24 | $13.3M | $4.6M | ||
| Q2 24 | $9.4M | $18.3M | ||
| Q1 24 | $10.7M | $3.0M |
| Q4 25 | 111.4% | 129.3% | ||
| Q3 25 | 44.7% | -48.3% | ||
| Q2 25 | 35.0% | -19.9% | ||
| Q1 25 | -1.7% | 3.5% | ||
| Q4 24 | 117.0% | -17.8% | ||
| Q3 24 | 39.1% | 8.7% | ||
| Q2 24 | 28.3% | 34.5% | ||
| Q1 24 | 33.9% | 5.4% |
| Q4 25 | 2.3% | 2.0% | ||
| Q3 25 | 0.8% | 0.1% | ||
| Q2 25 | 0.4% | 0.7% | ||
| Q1 25 | 1.5% | 0.5% | ||
| Q4 24 | 2.9% | 1.3% | ||
| Q3 24 | 0.7% | 0.8% | ||
| Q2 24 | 0.9% | 1.6% | ||
| Q1 24 | 0.2% | 1.3% |
| Q4 25 | 4.96× | 3.66× | ||
| Q3 25 | 1.56× | -1.63× | ||
| Q2 25 | 1.52× | -3.39× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | 6.03× | -1.12× | ||
| Q3 24 | 1.88× | 1.77× | ||
| Q2 24 | 0.86× | 1.04× | ||
| Q1 24 | 1.60× | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACNB
Segment breakdown not available.
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
